Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Colorectal Neoplasms

  Free Subscription


18.07.2022

3 Ann Surg
1 Ann Surg Oncol
1 BMC Gastroenterol
4 Cancer Lett
3 Clin Res Hepatol Gastroenterol
6 Dis Colon Rectum
1 Eur J Cancer
1 Gastroenterology
2 Gut
1 Hum Pathol
10 Int J Colorectal Dis
2 J Surg Oncol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg

  1. VARGHESE C, Wells CI, O'Grady G, Christensen P, et al
    The Longitudinal Course of Low-anterior Resection Syndrome: An individual Patient Meta-analysis.
    Ann Surg. 2022;276:46-54.
    PubMed         Abstract available

  2. VAN DER HEIJDEN JAG, Kalkdijk-Dijkstra AJ, Pierie JPEN, van Westreenen HL, et al
    Pelvic Floor Rehabilitation After Rectal Cancer Surgery: A Multicenter Randomized Clinical Trial (FORCE Trial).
    Ann Surg. 2022;276:38-45.
    PubMed         Abstract available

  3. ISHIBE A, Watanabe J, Suwa Y, Nakagawa K, et al
    A Prospective, Single-arm, Multicenter Trial of Diverting Stoma Followed by Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE Study).
    Ann Surg. 2022;276:140-145.
    PubMed         Abstract available


    Ann Surg Oncol

  4. PEDRAZZANI C, Turri G, Choi GS
    ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer.
    Ann Surg Oncol. 2022 Jul 12. pii: 10.1245/s10434-022-12180.
    PubMed        


    BMC Gastroenterol

  5. MIYAKITA H, Chan LF, Okada K, Kayano H, et al
    Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.
    BMC Gastroenterol. 2022;22:334.
    PubMed         Abstract available


    Cancer Lett

  6. ZHAO W, Jin L, Chen P, Li D, et al
    Colorectal cancer immunotherapy-Recent progress and future directions.
    Cancer Lett. 2022 Jul 7:215816. doi: 10.1016/j.canlet.2022.215816.
    PubMed         Abstract available

  7. SHIMIZU Y, Maruyama K, Suzuki M, Kawachi H, et al
    Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
    Cancer Lett. 2022;543:215799.
    PubMed         Abstract available

  8. CHEN TW, Hung WZ, Chiang SF, Chen WT, et al
    Dual inhibition of TGFbeta signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1.
    Cancer Lett. 2022;543:215795.
    PubMed         Abstract available

  9. SONG CH, Kim N, Nam RH, Choi SI, et al
    Combination treatment with 17beta-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model.
    Cancer Lett. 2022;543:215780.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  10. STEPHANE S, Timothee W, Jeremie A, Raphael O, et al
    Endoscopic submucosal dissection or piecemeal endoscopic mucosal resection for large superficial colorectal lesions: A cost effectiveness study.
    Clin Res Hepatol Gastroenterol. 2022;46:101969.
    PubMed         Abstract available

  11. ZHUANG Z, Yu B, Xie M, Zhang Y, et al
    Association of Helicobacter pylori enrichment in colorectal adenoma tissue on clinical and pathological features of adenoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101961.
    PubMed         Abstract available

  12. CARBONI F, Zazza S, Bertini L, Diodoro MG, et al
    Remarkable survival of operated stage IV gastric cancer with resected late isolated colon metastasis.
    Clin Res Hepatol Gastroenterol. 2022 Apr 7:101917.
    PubMed         Abstract available


    Dis Colon Rectum

  13. SCHLICK CJR, Huang R, Brajcich BC, Halverson AL, et al
    Unbundling Bundles: Evaluating the Association of Individual Colorectal Surgical Site Infection Reduction Bundle Elements on Infection Rates in a Statewide Collaborative.
    Dis Colon Rectum. 2022;65:1052-1061.
    PubMed         Abstract available

  14. NISHIZAKI D, Hida K, Sumii A, Okamura R, et al
    Laparoscopic Versus Open Surgery for Locally Advanced Rectal Cancer: Five-Year Survival Outcomes in a Large, Multicenter, Propensity Score-Matched Cohort Study.
    Dis Colon Rectum. 2022;65:1005-1014.
    PubMed         Abstract available

  15. ROUANET P, Rullier E, Lelong B, Maingon P, et al
    Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial.
    Dis Colon Rectum. 2022;65:986-995.
    PubMed         Abstract available

  16. WIDMANN B, Almarie B, Warschkow R, Beutner U, et al
    Advanced Lymph Node Staging With Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision for Rectal Cancer: A Retrospective Cohort Study.
    Dis Colon Rectum. 2022;65:1015-1024.
    PubMed         Abstract available

  17. SYLLA P
    Expert Commentary on Indications and Technical Considerations for Transanal Total Mesorectal Excision.
    Dis Colon Rectum. 2022;65:961-963.
    PubMed        

  18. MCFADGEN HL, Farooq AO
    Indications and Technical Considerations for Transanal Total Mesorectal Excision.
    Dis Colon Rectum. 2022;65:958-961.
    PubMed         Abstract available


    Eur J Cancer

  19. ROS J, Elez E
    Overcoming acquired MET amplification after encorafenib-cetuximab in BRAF-V600E mutated colorectal cancer.
    Eur J Cancer. 2022;172:326-328.
    PubMed        


    Gastroenterology

  20. BURNETT-HARTMAN AN, Murphy CC, Lee JK
    Novel, Emerging Risk Factors for Colorectal Cancer Remain Understudied.
    Gastroenterology. 2022 Jul 7. pii: S0016-5085(22)00745.
    PubMed        


    Gut

  21. ABRAHAMI D, Azoulay L
    Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'.
    Gut. 2021 Dec 2. pii: gutjnl-2021-326544. doi: 10.1136/gutjnl-2021-326544.
    PubMed        

  22. MONAHAN KJ, Davies MM, Abulafi M, Banerjea A, et al
    Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BS
    Gut. 2022 Jul 12. pii: gutjnl-2022-327985. doi: 10.1136/gutjnl-2022-327985.
    PubMed         Abstract available


    Hum Pathol

  23. JAKAB A, Patai AV, Micsik T
    Digital image analysis provides robust tissue microenvironment-based prognosticators in stage I-IV colorectal cancer patients.
    Hum Pathol. 2022 Jul 9. pii: S0046-8177(22)00176.
    PubMed         Abstract available


    Int J Colorectal Dis

  24. BAO QR, Pellino G, Spolverato G, Restivo A, et al
    The impact of anastomotic leak on long-term oncological outcomes after low anterior resection for mid-low rectal cancer: extended follow-up of a randomised controlled trial.
    Int J Colorectal Dis. 2022;37:1689-1698.
    PubMed         Abstract available

  25. JACKISCH J, Jackisch T, Roessler J, Sims A, et al
    Tailored concept for the plastic closure of pelvic defects resulting from extralevator abdominoperineal excision (ELAPE) or pelvic exenteration.
    Int J Colorectal Dis. 2022;37:1669-1679.
    PubMed         Abstract available

  26. MYRSETH E, Nymo LS, Gjessing PF, Norderval S, et al
    Diverting stomas reduce reoperation rates for anastomotic leak but not overall reoperation rates within 30 days after anterior rectal resection: a national cohort study.
    Int J Colorectal Dis. 2022;37:1681-1688.
    PubMed         Abstract available

  27. ZHANG H, Li G, Cao K, Zhai Z, et al
    Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival.
    Int J Colorectal Dis. 2022;37:1657-1668.
    PubMed         Abstract available

  28. BURGHGRAEF TA, Crolla RMPH, Fahim M, van der Schelling GP, et al
    Local recurrence of robot-assisted total mesorectal excision: a multicentre cohort study evaluating the initial cases.
    Int J Colorectal Dis. 2022;37:1635-1645.
    PubMed         Abstract available

  29. BARENBOIM A, Geva R, Tulchinsky H
    Revised risk factors and patient characteristics for failure to close a defunctioning ileostomy following low anterior resection for locally advanced rectal cancer.
    Int J Colorectal Dis. 2022;37:1611-1619.
    PubMed         Abstract available

  30. CHEN X, Wang W, Chen J, Xu L, et al
    Predicting pathologic complete response in locally advanced rectal cancer patients after neoadjuvant therapy: a machine learning model using XGBoost.
    Int J Colorectal Dis. 2022;37:1621-1634.
    PubMed         Abstract available

  31. YANG IJ, Suh JW, Lee J, Ahn HM, et al
    Comparison of tumor regression grade and clinical stage based on MRI image as a selection criterion for non-radical management after concurrent chemoradiotherapy in locally advanced rectal cancer: a multicenter, retrospective, cross-sectional study.
    Int J Colorectal Dis. 2022;37:1561-1568.
    PubMed         Abstract available

  32. TEI M, Suzuki Y, Ohtsuka M, Iwamoto K, et al
    Comparison of clinical outcomes of single-incision versus multi-port laparoscopic surgery for rectosigmoid or upper rectal cancer.
    Int J Colorectal Dis. 2022;37:1553-1560.
    PubMed         Abstract available

  33. TAN S, Xu C, Ma H, Chen S, et al
    Local resection versus radical resection for early-stage rectal cancer: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2022;37:1467-1483.
    PubMed         Abstract available


    J Surg Oncol

  34. GAWDI R, Valenzuela CD, Moaven O, Stauffer JA, et al
    Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    J Surg Oncol. 2022;126:339-347.
    PubMed         Abstract available

  35. GUGUSHEFF J, White K, Fitzadam S, Creighton N, et al
    Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer.
    J Surg Oncol. 2022;126:322-329.
    PubMed         Abstract available


    PLoS One

  36. CHEE CW, Zamakshshari NH, Lee VS, Abdullah I, et al
    Morindone from Morinda citrifolia as a potential antiproliferative agent against colorectal cancer cell lines.
    PLoS One. 2022;17:e0270970.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: